Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A drug repurposing screen identifies antiviral compounds against Puumala Orthohantavirus.

Scientific reports·2026
Same author

Tick-borne encephalitis: emerging clinical trends and challenges.

Trends in molecular medicine·2026
Same author

Signs of Cross-Reactivity Between SARS-CoV-2 and Other Coronaviruses in a Pre-Vaccine Swedish School Setting.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Diagnostic value of RT-PCR for detection of tick-borne encephalitis virus RNA in cerebrospinal fluid.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Altered DNA Methylation Pattern Contributes to Differential Epigenetic Immune Signaling in the Upper Respiratory Airway of Unvaccinated COVID-19 Patients.

Cells·2025
Same author

Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in Sweden.

Open forum infectious diseases·2025

Related Experiment Video

Updated: Sep 7, 2025

Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies
04:47

Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies

Published on: December 1, 2023

751

Deaths from Tick-Borne Encephalitis, Sweden.

Renata Varnaitė, Sara Gredmark-Russ, Jonas Klingström

    Emerging Infectious Diseases
    |June 22, 2022
    PubMed
    Summary

    Tick-borne encephalitis (TBE) in Sweden showed a standardized mortality ratio of 3.96 between 2004-2017. No fatal TBE cases occurred in individuals under 40, highlighting the need for increased vaccination in at-risk groups.

    Keywords:
    SwedenTBEcase-fatality ratestandardized mortality ratiotick-borne encephalitisticksvector-borne infectionsviruses

    More Related Videos

    Tick Artificial Membrane Feeding for Ixodes scapularis
    08:53

    Tick Artificial Membrane Feeding for Ixodes scapularis

    Published on: November 30, 2022

    3.5K
    Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
    08:23

    Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research

    Published on: August 31, 2013

    13.3K

    Related Experiment Videos

    Last Updated: Sep 7, 2025

    Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies
    04:47

    Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies

    Published on: December 1, 2023

    751
    Tick Artificial Membrane Feeding for Ixodes scapularis
    08:53

    Tick Artificial Membrane Feeding for Ixodes scapularis

    Published on: November 30, 2022

    3.5K
    Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
    08:23

    Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research

    Published on: August 31, 2013

    13.3K

    Area of Science:

    • Epidemiology
    • Infectious Diseases
    • Public Health

    Background:

    • Tick-borne encephalitis (TBE) is a significant viral infection transmitted by ticks.
    • Understanding TBE's mortality patterns is crucial for public health interventions.
    • Sweden has endemic regions where TBE poses a risk.

    Purpose of the Study:

    • To determine the standardized mortality ratio (SMR) for TBE in Sweden.
    • To analyze TBE-related mortality trends from 2004 to 2017.
    • To identify demographic factors associated with TBE fatality.

    Main Methods:

    • Retrospective analysis of TBE cases and mortality data in Sweden.
    • Calculation of standardized mortality ratio (SMR) for TBE.
    • Stratification of mortality data by age groups.

    Main Results:

    • The overall SMR for TBE in Sweden was 3.96 (95% CI 2.55-5.90).
    • No fatal TBE cases were recorded in patients younger than 40 years.
    • The data indicates a higher mortality risk in older age groups.

    Conclusions:

    • TBE poses a notable mortality risk in Sweden, particularly for individuals aged 40 and above.
    • The findings emphasize the critical need for enhanced TBE vaccination strategies.
    • Targeted vaccination campaigns in at-risk populations are essential to reduce TBE-related deaths.